93.61USD-0.17%Mkt Cap: —P/E: 25.061d ago
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three seg…
Industry Peers
Health Information Services$38.07BUSDP/E 44.2
$40.77BUSDP/E 44.6
$11.74BUSDP/E 53.0
$11.05BUSD
$8.71BUSDP/E 38.9
$8.10BUSD
$7.14BUSDP/E 10.8
$4.76BUSDP/E 35.5
$4.62BUSDP/E 30.9
$3.96BUSD
$2.75BUSDP/E 97.7
$1.66BUSDP/E 43.4
$1.50BUSDP/E 36.5
$1.48BUSD
$1.28BUSD
$1.21BUSDP/E 59.0
$1.18BUSD
$870.57MUSD
$834.80MUSDP/E 39.7
$738.82MUSDP/E 74.8
Key Statistics
Company
Market Cap—
Enterprise Value138.81B $
Revenue (TTM)36.36B $
Gross Profit23.75B $
Net Income (TTM)4.80B $
Revenue/Share28.37 USD
Last Price93.61 USD
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees95.0K
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINIE00BTN1Y115
Valuation
P/E (Trailing)25.06
P/E (Forward)—
PEG—
EV/EBITDA13.74
EV/Revenue3.82
P/S—
P/B2.40
EPS (TTM)3.73
EPS (Forward)—
52W Range
90.0072% of range95.00
52W High95.00 USD
52W Low90.00 USD
Profitability
Gross Margin65.31%
Oper. Margin22.05%
EBITDA Margin27.78%
Profit Margin13.20%
ROE9.84%
ROA4.92%
Growth
Revenue Growth9.90%
Earnings Growth18.30%
Cash Flow & Leverage
Operating CF7.33B $
CapEx (TTM)—
FCF Margin12.72%
FCF Yield—
Net Debt19.93B $
Net Debt/EBITDA1.97
Balance Sheet
Debt/Equity58.21
Current Ratio2.13
Quick Ratio1.36
Book Value/Sh38.64 USD
Cash/Share7.203 USD
Dividends
Fwd Div Rate—
Trail. Div Rate2.840 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.34B
Float1.28B
Insiders0.32%
Institutions88.67%
Technical
SMA 5085.63 (+9.3%)
SMA 20082.06 (+14.1%)
Beta0.57
S&P 52W Chg20.80%
Avg Vol (30d)3.58K
Avg Vol (10d)3.70K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—